Comparison

Recombinant Human FHIT GST

Item no. CS-CRF126A
Manufacturer Cell Sciences
Amount 2 ug
Category
Type Proteins
Specific against Human (Homo sapiens)
Conjugate/Tag GST
Purity FHIT Human Recombinant full length protein expressed in, E. coli, , shows a 43 kDa band on SDS-PAGE. The FHIT is fused to GST-Tag and purified by proprietary chromatographic techniques.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products 5'''-P1, AP3Aase, FRA3B, AP3A hydrolase, P3-triphosphate hydrolase, dinucleosidetriphosphatase, tumor suppressor protein, bis(5'-adenosyl)-triphosphatase, diadenosine 5'
Available
Manufacturer - Category
Biomolecules
Storage Conditions
Store vial at -20C to -80C. When stored at the recommended temperature, this protein is stable for 12 months. Please prevent freeze-thaw cycles.
Molecular Weight
43 kDa band on SDS-PAGE.
Description
FHIT is a member of the histidine triad gene family. FHIT gene encodes a diadenosine 5', 5'''-P1, P3-triphosphate hydrolase involved in purine metabolism. FHIT gene includes the common fragile site FRA3B on chromosome 3, where carcinogen-induced damage can lead to translocations and abnormal transcripts of this gene. The FHIT protein is a tumor suppressor with reduced or no expression in numerous types of cancer. FHIT may also act as a tumor suppressor in normal cells. Alterations and deletions of the FHIT (Fragile Histidine Triad) gene are strongly linked to the genesis and establishment of human tumors of the lung, cervix, breast, colon, stomach, and pancreas. The expression of FHIT is more often lost in cancers of individuals with familial mutations causing deficiency in DNA repair genes such as BRCA1, BRCA2 and MSH2. in vitro, FHIT functions as a hydrolase that cleaves diadenosine triphosphate (Ap3A) to ADP and AMP.. The FHIT -Ap3A enzyme-substrate complex seems to be the tumor suppressor signal. The restoration of FHIT expression in FHIT -deficient cancer cells leads to apoptosis, involving the intrinsic caspase pathway, in cancer-derived cells and in tumor xenografts.
Formulation
FHIT in 50 mM Tris-Acetate, pH7.5 + 1mM EDTA and 20% Glycerol.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close